RT Journal Article
SR Electronic
T1 METABOLISM AND BILIARY EXCRETION OF ETHACRYNIC ACID
JF Journal of Pharmacology and Experimental Therapeutics
JO J Pharmacol Exp Ther
FD American Society for Pharmacology and Experimental Therapeutics
SP 548
OP 556
VO 191
IS 3
A1 Klaassen, Curtis D.
A1 Fitzgerald, Thomas J.
YR 1974
UL http://jpet.aspetjournals.org/content/191/3/548.abstract
AB Within 4 hours after i.v. administration (5 or 50 mg/kg) of 14C-ethacrynic acid (EA), 60 to 70% was excreted into the bile of rats. Less than 25% was EA and the remainder was biotransformation products. The two major metabolites in bile were identified; one was the glutathione adduct of EA (EA-GSH) and the other was EA-mercapturate. Approximately 40% of either dose was excreted as EA-GSH. EA-mercapturate accounted for 18% of the low dose and 30% of the high dose excreted into bile. Dogs excreted 57% of a 5 mg/kg dose (i.v.) into bile within 4 hours. Less EA was metabolized by the dog than the rat; 38% of the radioactivity excreted into dog bile was in the form of the parent drug. In addition to the two metabolites of EA found in rat bile, the dog formed a cysteine adduct of EA (EA-cysteine). The dog excreted 25, 11 and 9% of the dose of EA as EA-mercapturate, EA-cysteine and EA-GSH, respectively. Seventeen percent of the 14C excreted into the bile remained unidentified. © 1974 by The Williams & Wilkins Co.